ARNETT JEAN M 4
4 · Cell MedX Corp. · Filed Sep 1, 2020
Insider Transaction Report
Form 4
Cell MedX Corp.CMXC
ARNETT JEAN M
DirectorVP, Corporate Strategy10% Owner
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2020-08-13+1,250,000→ 0 totalExercise: $0.05From: 2015-08-20Exp: 2020-08-20→ Common Stock (1,250,000 underlying) - Exercise/Conversion
Common Shares
2020-08-13$0.05/sh+1,250,000$62,500→ 6,250,000 total